CDC-RFA-OE15-15010201SUPP17.pdf

Centers for Disease Control

Center for Surveillance, Epidemiology and Laboratory Services

PPHF 2017: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-financed in part by 2017 Prevention and Public Health Funds

CDC-RFA-OE15-15010201SUPP17

Application Due Date: 04/28/2017

PPHF 2017: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-financed in part by 2017 Prevention and Public Health Funds

CDC-RFA-OE15-15010201SUPP17

TABLE OF CONTENTS

Part 1. Overview Information Part 2. Full Text of the Announcement

Section I. Funding Opportunity Description Section II. Award Information Section III. Eligibility Information Section IV. Application and Submission Information Section V. Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII. Other Information

Part 1. Overview Information Federal Agency Name:

Federal Centers for Disease Control and Prevention (CDC) Funding Opportunity Title:

PPHF 2017: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-financed in part by 2017 Prevention and Public Health Funds Announcement Type:

Revision - Type 3 (Non-competitive Supplement)

Agency Funding Opportunity Number:

CDC-RFA-OE15-15010201SUPP17

Catalog of Federal Domestic Assistance Number:

93.064 93.322 93.765 Key Dates:

Due Date for Application: 04/28/2017 Application must be successfully submitted to Grants.gov by 11:59pm Eastern Standard Time on the deadline date.

Additional Overview Content:

All projects proposed for Zika activites must be within the scope of the FOA; clearly identified; and specifcally address Zika requirements.

Executive Summary:

CDC announces this supplemental funding opportunity in support of CDC-RFA-OE15-1501. The supplemental funds awarded will improve the effectiveness, capabilities and sustainability of public health laboratories (PHLs) individually and as components of a national PHL system. Activities conducted will use science-based knowledge to identify best practices that will improve effectiveness, capabilities and sustainability.

Public Health Laboratory Preparedness and Response for Zika.

This supplemental funding opportunity solicits a proposal for new and/or expanded activities. All projects proposed for Zika activites must be within the scope of the FOA; clearly identified; and specifcally address Zika requirements.

Available funding: $250,000

Recipient Activities:

Conduct preparedness assessments, facilitate evaluations of new technologies and methods, develop resources and provide technical assistance to state and local PHLs to ensure capability and capacity to respond to all public health threats.

Promote national, state and local PHL systems that collaborate with clinical laboratories.

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the CSELS:

Program-specific proposed projects will achieve the following:

Performance Goal:

The goal of this supplemental funding is to strengthen the effectiveness, capabilities, and sustainability of public health laboratories to respond to Zika disease.

Long-term outcomes are:

(1) Reduced incidence and prevalence of preventable diseases and public health threats; (2) Reduced morbidity and mortality equitably delivered throughout the United States and the world; (3) Protection of the public from public health threats; (4) Sustainable and resilient PHLs that effectively and efficiently adapt to evolving public health needs; (5) Changes in regulations resulting in a more efficient, quality, and safe PHL system; and (6) Revised standards for the PHL system resulting in a more efficient, higher quality, and safe PHL system.

Mid-term outcomes are:

(1) Improved completeness and timeliness of reporting of Zika virus surveillance data, including clinical, exposure, and laboratory data, to state health departments and CDC; (2) More rapid and complete identification of Zika virus disease outbreaks to facilitate timely and effective control measures; (3) Timely and accurate information on Zika virus disease activity provided to healthcare providers, researchers, political leaders, and general public: (4) Improved human surveillance and laboratory capacity to monitor the epidemiology, incidence, and geographic distribution of women and infants who meet the U.S. Zika Pregnancy Registry case definition; and (5) Translation of public health data real time into clinical and public health recommendations.

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public -health-research-nonresearch.pdf.

Part 2. Full Text Section I. Funding Opportunity Description

Statutory Authority This Cooperative Agreement is authrorized under sections 317(k)(2) and 307 of the Public Health Service Act [42 U.S.C. §§ 247b(k)(2) and 242l] and Section 4002 of the Patient Protection and Affordable Care Act, Prevention and Public Health Funds [42 U.S.C. §300u-11].

Background N/A

Purpose The purpose of this supplement to he cooperative agreement aims to promote quality and safe PHL practice;

http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

The purpose of this supplement to he cooperative agreement aims to promote quality and safe PHL practice;

improve PHL infrastructure; strengthen the PHL system and develop a well-trained PHL workforce.

Activities conducted will use science-based knowledge to identify best practices that will improve PHL effectiveness, capabilities and sustainability. Public Health laboratories will become a much stronger component of the public health and healthcare systems as a result of the activities undertaken.

Program Implementation

Recipient Activities Organizational Capacity to Execute the Approach: The awardee must demonstrate organizational capacity to effectively conduct the proposed "new" and expansion activities as reflected in CDC-RFA-OE15-1501.

Workplan: The awardee must provide a workplan for each cross-cutting and program-specific project that maps to strategies and activities Workplans must demonstrate alignment between activities (with appropriate performance measures and milestones for accomplishing tasks) and achievement of outcomes reflected in

CDC-RFA-OE15-1501.

In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.

CDC Activities Monitoring activities include routine and on-going communications between CDC and the awardee, site visits, and awardee reporting (including work plans, performance and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements.

Tracking awardee progress in achieving the desired outcomes Ensuring the adequacy of awardee systems that underlie and generate data reports Creating an environment that fosters integrity in program performance and results

Monitoring may also include the following activities:

Ensuring that workplans are feasible based on the budget and consistent with the intent of the award Ensuring that the awardee is performing at a sufficient level to achieve outcomes within stated timeframes Working with the awardee to adjust workplans based on achievement of outcomes within stated timeframes Working with the awardee to adjust workplans based on achievement of outcomes, evaluation results and changing budgets Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

Section II. Award Information

Type of Award: Cooperative Agreement CDC substantial involvement in this program appears in the Activities

Section above.

Award Mechanism: U60

Fiscal Year Funds: 2017 Approximate Total Supplemental Funding:

$250,000

This amount is subject to availability of funds. Includes direct and indirect costs.

CDC/CSELS will provide overall guidance on resource allocation during a pre-application informational call.

Approximate Number of Awards: 1

Approximate Average Award: $32,250,000 This amount is for the budget period only and includes direct costs and indirect costs as applicable.

Floor of Individual Award Range: $250,000 Ceiling of Individual Award Range:

$0

This ceiling is for a 12-month budget period.

Anticipated Award Date: 03/30/2017 Budget Period Length: 12 month(s) Project Period Length: 5 year(s)

Section III. Eligibility Information

Eligible Applicants The following recipients may submit an application:

Eligibility Category: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses

This Funding Opportunity Announcement is a single-source eligibility. The single-source grantee is the Association of Public Health Laboratories (APHL). No other applications are sought.

Required Registrations

System for Award Management and Universal Identifier Requirements An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System: All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements. The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or Internet at http://fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be provided at no charge. If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM): The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All http://www.grants.gov http://fedgov.dnb.com/webform/displayHomePage.do an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process usually requires not more than five business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov: The first step in submitting an application online is registering your organization through www.grants.gov, the official HHS E-grant website. Registration information is located at the "Get Registered" option at www.grants.gov. All applicant organizations must register with www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants must start the registration process as early as possible.

Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

Other

Special Requirements The grantee is advised that any activities involving information collection (i.e., surveys, questionnaires, etc.)

from 10 or more non-Federal individuals/entities are subject to OMB/PRA requirements and may require the CDC to coordinate an OMB Information Collection Clearance.

Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

Maintenance of Effort

Section IV. Application and Submission Information

Address to Request Application Package Applicants must download the application package associated with this funding opportunity from Grants.gov. If access to the Internet is not available or if the applicant encounters difficulty accessing the forms on-line, contact the HHS/CDC Office of Grants Services (OGS) Technical Information Management Section (TIMS) staff at (770) 488-2700 for further instruction. CDC Telecommunications for the hearing impaired or disable is available at: TTY 1-888-232-6348.

If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it is needed. You can reach the Grants.gov Support Center at 1-800-518-4726 or by email at support@grants.gov. Submissions sent by email, fax, CD’s or thumb drives of applications will not be accepted.

Content and Form of Application Submission Unless specifically indicated, this announcement requires submission of the following information:

N/A. This is a supplemental amendment to the original FOA.

http://www.sam.gov/ http://www.grants.gov http://www.grants.gov http://www.grants.gov http://www.grants.gov mailto:support@grants.gov

A Project Abstract must be completed in the Grants.gov application forms. The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This abstract must not include any proprietary/confidential information.

N/A. This is a supplemental amendment to the original FOA.

A Project Narrative must be submitted with the application forms. The project narrative must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format:

Maximum number of pages: 10. If your narrative exceeds the page limit, only the first pages which are within the page limit will be reviewed.

Font size: 12 point unreduced, Times New Roman Double spaced Page margin size: One inch Number all narrative pages; not to exceed the maximum number of pages.

The narrative should address activities to be conducted over the entire project period and must include the following items in the order listed.

Additional information may be included in the application appendices. The appendices must be uploaded to the "Other Attachments Form" of application package in Grants.gov. Note: appendices will not be counted toward the narrative page limit. This additional information includes:

N/A

Additional information submitted via Grants.gov must be uploaded in a PDF file format, and should be named:

N/A

No more than 25 electronic attachments should be uploaded per application.

CDC Assurances and Certifications: All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Submission Dates and Times This announcement is the definitive guide on application content, submission, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline published herein, it will not be eligible for review and the recipient will be notified the application did not meet the submission requirements.

This section provides applicants with submission dates and times. Applications that are submitted after the http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx deadlines will not be processed.

If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Application Deadline Date Due Date for Applications: 04/28/2017

Explanation of Deadlines: Application must be successfully submitted to Grants.gov by 11:59pm Eastern Standard Time on the deadline date.

Intergovernmental Review

Executive Order 12372 does not apply to this program.

Pilot Program for Enhancement of Employee Whistleblower Protections All applicants will be subject to a term and condition that applies the terms of 48 CFR section 3.908 to the award and requires that grantees inform their employees in writing (in the predominant native language of the workforce) of employee whistleblower rights and protections under 41 U.S.C 4712.

Copyright Interest Provisions This provision is intended to ensure that the public has access to the results and accomplishments of public health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy, Recipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the final, peer-reviewed manuscript of any such work developed under this award upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Also at the time of submission, Recipient and/or the Recipient’s submitting author must specify the date the final manuscript will be publicly accessible through PubMed Central (PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through PMC within twelve (12) months of the publisher's official date of final publication; however the author is strongly encouraged to make the subject manuscript available as soon as possible. The recipient must obtain prior approval from the CDC for any exception to this provision.

The author's final, peer-reviewed manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process, and all graphics and supplemental material associated with the article. Recipient and its submitting authors working under this award are responsible for ensuring that any publishing or copyright agreements concerning submitted articles reserve adequate right to fully comply with this provision and the license reserved by CDC. The manuscript will be hosted in both PMC and the CDC Stacks institutional repository system. In progress reports for this award, recipient must identify publications subject to the CDC Public Access Policy by using the applicable NIHMS identification number for up to three (3) months after the publication date and the PubMed Central identification number (PMCID) thereafter.

Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, www.USASpending.gov.

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all http://www.USASpending.gov sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

http:// frwebgate.access.gpo.gov /cgi-bin/getdoc.cgi ?dbname= 109_cong_bills&docid= f:s2590enr.txt.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf

Funding Restrictions Restrictions, which must be taken into account while writing the budget, are as follows:

Recipients may not use funds for research.

Recipients may not use funds for clinical care.

Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

Other than for normal and recognized executive-legislative relationships, no funds may be used for: publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body.

See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC awardees

The recipient can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address: http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html

Other Submission Requirements

Application Submission Submit the application electronically by using the forms and instructions posted for this funding opportunity on www.Grants.gov. If access to the Internet is not available or if the recipient encounters difficulty in accessing the forms on-line, contact the HHS/CDC Office of Grants Services (OGS) Technical Information Management Section (TIMS) staff at (770) 488-2700 for further instruction.

Note: Application submission is not concluded until successful completion of the validation process. After submission of your application package, recipients will receive a "submission receipt" email generated by Grants.gov. Grants.gov will then generate a second e-mail message to recipients which will either validate or reject their submitted application package. This validation process may take as long as two (2) business days. Recipients are strongly encouraged check the status of their application to ensure submission of their application package is complete and no submission errors exists. To guarantee that you comply with the application deadline published in the Funding Opportunity Announcement, recipients are also strongly encouraged to allocate additional days prior to the published deadline to file their application.

Non-validated applications will not be accepted after the published application deadline date.

In the event that you do not receive a "validation" email within two (2) business days of application http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s2590enr.txt.pdf http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s2590enr.txt.pdf https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html http://www.Grants.gov submission, please contact Grants.gov. Refer to the email message generated at the time of application submission for instructions on how to track your application or the Application User Guide, Version 3.0 page 57.

Electronic Submission of Application:

Applications must be submitted electronically at www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully made available to CDC for processing from Grants.gov on the deadline date.

The application package can be downloaded from www.Grants.gov. Recipients can complete the application package off-line, and then upload and submit the application via the Grants.gov website. The recipient must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov website. Use of file formats other than PDF may result in the file being unreadable by staff.

Applications submitted through www.Grants.gov, are electronically time/date stamped and assigned a tracking number. The AOR will receive an e-mail notice of receipt when HHS/CDC receives the application.

The tracking number serves to document submission and initiate the electronic validation process before the application is made available to CDC for processing.

If the recipient encounters technical difficulties with Grants.gov, the recipient should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week. The Contact Center provides customer service to the recipient community. The extended hours will provide recipients support around the clock, ensuring the best possible customer service is received any time it’s needed. You can reach the Grants.gov Support Center at 1-800-518-4726 or by email at support@grants.gov.

Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.

Organizations that encounter technical difficulties in using www.Grants.gov to submit their application must attempt to overcome those difficulties by contacting the Grants.gov Support Center (1-800-518-4726, support@grants.gov). After consulting with the Grants.gov Support Center, if the technical difficulties remain unresolved and electronic submission is not possible to meet the established deadline, organizations may submit a request prior to the application deadline by email to the Grants Management Specialist/Officer for permission to submit a paper application. An organization's request for permission must: (a) include the Grants.gov case number assigned to the inquiry, (b) describe the difficulties that prevent electronic submission and the efforts taken with the Grants.gov Support Center (c) be submitted to the Grants Management Specialist/Officer at least 3 calendar days prior to the application deadline. Paper applications submitted without prior approval will not be considered.

If a paper application is authorized, the recipient will receive instructions from OGS TIMS to submit the original and two hard copies of the application by mail or express delivery service.

Section V. Application Review Information

Eligible recipients are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the CDC-RFA-OE15-15010201SUPP17. Measures of effectiveness must relate to the performance goals stated in the "Purpose" section of this announcement.

Measures of effectiveness must be objective, quantitative and measure the intended outcome of the proposed program. The measures of effectiveness must be included in the application and will be an element of the evaluation of the submitted application.

http://www.Grants.gov

Criteria Eligible recipients will be evaluated against the following criteria:

Approach Maximum Points: 50

The submitted application will undergo a structured review to ensure that the proposed activities are technically sound and anticipated outcomes can be achieved.

- Does the applicant provide a detailed workplan which adequately describes proposed objectives?

- Are the anticipated outcomes realistic?

- Is the proposed timeline reasonable?

- Will the proposed approach improve the effectiveness, capabilities and sustainability of PHL's?

Applicant's Organizational Capacity to Implement the Approach Maximum Points: 35

- Does the applicant demonstrate sufficient organizational capacity to achieve anticipated outcomes?

- Does the applicant demonstrate appropriate, existing infrastructure and skill sets to carry-out the proposed activity?

- Does the applicant demonstrate the expertise, experience and capacity to successfully represent the interests, input and perspective of PHLs and CDC?

Evaluation and Performance Management Maximum Points: 15

- Does the applicant plan address the overall impact of project area activities in strengthening PHL's both domestically and abroad?

- Does the applicant present a plan to measure performance during the proposed timeline?

Review and Selection Process

Review Eligible applications will be jointly reviewed for responsiveness by CSELS and PGO. Incomplete applications and applications that are non-responsive will not advance through the review process.

Recipients will be notified in writing of the results.

An objective review panel will evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information, subsection entitled “Criteria”.

Selection

CDC will provide justification for any decision to fund out of rank order.

Anticipated Announcement and Award Dates

Section VI. Award Administration Information

Award Notices Successful recipients will receive a Notice of Award (NoA) from the CDC Office of Grants Services. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application.

Unsuccessful recipients will receive notification of the results of the application review by mail.

Administrative and National Policy Requirements Successful recipients must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) 2 Part 215 or Part 92, as appropriate. For competing supplements, ARs remain in effect as published in the original announcement.

Continuing Continuations - AR-4 HIV/AIDS Confidentiality Provisions

AR-5 HIV Program Review Panel Requirements

AR-9 Paperwork Reduction Act Requirements

AR-10 Smoke-Free Workplace Requirements

AR-11 Healthy People 2020

AR-12 Lobbying Restrictions

AR-13 Prohibition on Use of CDC Funds for Certain Gun Control Activities

AR-14 Accounting System Requirements

AR-15 Proof of Non-Profit Status

AR-18 Cost Recovery-ATSDR

AR-19 Third Party Agreements-ATSDR

AR-20: Conference Support

AR-21 Small, Minority, and Women-Owned Business

AR-25 Release and Sharing of Data

AR-26 National Historic Preservation Act of 1966 (Public Law 89-665, 80 Stat. 915)

AR-27 Conference Disclaimer and Use of Logos

AR-29 Compliance with E.O. 13513 Federal Leadership on Reducing Text Messaging While Driving, October 1, 2009.

AR-30 Information Letter 10-006. – Compliance with Section 508 of the Rehabilitation Act of 1973

AR-32 Enacted General Provisions

AR-33: Plain Writing Act of 2010

AR-34: Language Access for Persons with Limited English Proficiency

AR-35: Nutrition Policies

For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.

http://www.access.gpo.gov/nara/cfr/cfr-table-search.html

Reporting Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, http://www.USASpending.gov Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

http:// frwebgate. access. gpo.gov /cgi-bin /getdoc.cgi ?dbname= 109_cong_bills &docid= f:s2590enr .txt.pdf https://www.fsrs.gov /documents /ffata_legislation_ 110_252.pdf

Section VII. Agency Contacts

CDC encourages inquiries concerning this announcement.

For programmatic technical assistance and general inquiries, contact:

Annie Harrison-Camacho, Project Officer Department of Health and Human Services Centers for Disease Control and Prevention

1600 Clifton Road, NE, MS E94 Atlanta, GA 30333 Telephone: (404) 498-6451 Email: ATC4@cdc.gov

For application submission questions, contact:

Technical Information Management Section Department of Health and Human Services CDC Office of Grants Services 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Telephone: 770-488-2700 Email: ogstims@cdc.gov Nicole Comick, Grants Management Specialist Department of Health and Human Services Office of Grants Services 2960 Brandywine Road

MS E-19

Atlanta, GA 30341 Telephone: (404) 718-5907 Email: ktv6@cdc.gov

Section VIII. Other Information http://www.USASpending.gov http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s2590enr.txt.pdf http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s2590enr.txt.pdf https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf mailto:ATC4@cdc.gov mailto:pgotim@cdc.gov mailto:ktv6@cdc.gov

Other CDC funding opportunity announcements can be found at www.grants.gov.

http://www.grants.gov/